Search results
Results from the WOW.Com Content Network
A Lyme disease vaccine has entered phase 3 clinical trials, per Pfizer. Here's how the vaccine works, when it might become available, and who it might benefit.
The companies at the time did not disclose the name of the contractor or the number of affected patients. The vaccine for Lyme disease, which causes infections that are transmitted to humans ...
Lyme disease has become an insidious epidemic in the United States. Caused by bacteria transmitted by an infected tick bite, symptoms can include arthritis, cardiac and neurological problems if ...
A new Lyme disease vaccine is set to enter Phase 3 trials, representing a major step forward in preventing the tick-borne illness. Lyme disease vaccine may help people with long-term symptoms ...
Lyme disease, also known as Lyme borreliosis, is a tick-borne disease caused by species of Borrelia bacteria, transmitted by blood-feeding ticks in the genus Ixodes. [4] [9] [10] The most common sign of infection is an expanding red rash, known as erythema migrans (EM), which appears at the site of the tick bite about a week afterwards. [1]
Pfizer, the maker of a COVID-19 vaccine, announced Monday it is starting a phase 3 clinical trial on its Lyme disease vaccine, known as VLA15. The study will include over 6,000 participants from ...
1989 – First vaccine for Q fever [12] 1990 – First vaccine for hantavirus hemorrhagic fever with renal syndrome; 1991 – First vaccine for hepatitis A [13] 1998 – First vaccine for Lyme disease; 1998 – First vaccine for rotavirus [14]
Researchers are seeking thousands of volunteers in the U.S. and Europe to test the first potential vaccine against Lyme disease in 20 years -- in hopes of better fighting the tick-borne threat.